#48 - Michael Oleksiw, CEO at Pleio
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
#48 - Michael Oleksiw, CEO at Pleio
-
Narrated by:
-
By:
About this listen
Join us on the latest episode! Our Guest: Michael Oleksiw, CEO at Pleio.
What you'll get out of this episode:
- Human + AI Synergy: Pleio combines emotionally aware AI with peer-to-patient support to boost medication adherence.
- Overcoming Emotional Barriers: Emotions like fear, loneliness, and stigma are major challenges after diagnosis.
- Real-World Impact: Pleio's approach improved adherence rates by up to 28% in GLP-1 medication trials.
- Ethical AI in Healthcare: Patient data is de-identified and overseen by a medical board to ensure ethical use.
- Laser Focus on Loneliness: Pleio’s next frontier is tackling loneliness as a primary emotional barrier in healthcare.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michaeloleksiw/
Company LinkedIn https://www.linkedin.com/company/pleio-inc/
Website http://www.pleio.com
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet